Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

Objective: While multiple sclerosis (MS) is considered the cornerstone of autoimmune demyelinating CNS disorders, systemic autoimmune diseases (SADs) are important MS mimickers. We sought to explore whether distinct clinical, laboratory, and imaging characteristics along with quantitation of periphe...

Full description

Bibliographic Details
Main Authors: Dimitris K. Karathanasis, Anna Rapti, Adrianos Nezos, Charalampos Skarlis, Constantinos Kilidireas, Clio P. Mavragani, Maria Eleftheria Evangelopoulos
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
type I interferon score
multiple sclerosis
systemic autoimmune disease
MS-like
demyelination
neuropsychiatric lupus
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.898049/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.898049/full

Similar Items